Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | HCID 69058107 | HCID 69058107 | — |
| Solvent | 1-Propanol | HCID 1031 | — |
| Product | HCID 69058106 | HCID 69058106 | — |
Reaction Steps
0.5 g (0.79 mmol) 4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-(1R)-1-[(4-hydroxy-3,5-dimethylphenyl)methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-2-oxoethyl 1-piperidinecarboxylate are suspended in 5 ml n-propanol at ambient temperature and heated to 70° C. After the addition of 157 μl hydrobromic acid (30% in glacial acetic acid) the mixture is stirred for 1 hour at 70° C. and 20 hours at 40° C. Then the suspension formed is cooled to ambient temperature, stirred for 5 hours and filtered. The residue is dried for 4 hours at 80° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07638625B2 |
|---|
| Source dataset | uspto-grants-2009_12 |
|---|
| ORD ID | ord-80aa1b2170ed4943a2a7df02c37832d1 |
|---|
| Source note | uspto-grants-2009_12 |
|---|